Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Japanese Journal of Clinical Oncology|April 12, 2017
Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the worldAtsuo Takashima, Sakura Iizumi, Narikazu Boku
Japanese Journal of Clinical Oncology|November 18, 2020
Current status and perspectives of immune checkpoint inhibitors for colorectal cancerHidekazu Hirano, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2018
Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysisSakura Iizumi, Atsuo Takashima, Kentaro Sakamaki, et al.
Japanese Journal of Clinical Oncology|July 31, 2012
Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A)Kenichi Nakamura, Taro Shibata, Atsuo Takashima, et al.
Journal of Cardiology|September 1, 2004
[Isolated left ventricular noncompaction in the elderly: a case report]Atsuo Takashima, Masatoshi Shimizu, Kazuhiro Tatsumi, et al.
International Journal of Molecular Sciences|January 21, 2023
Current Targeted Therapy for Metastatic Colorectal CancerTomokazu Ohishi, Mika K Kaneko, Yukihiro Yoshida, et al.
Gastrointestinal Cancer Research : GCR|December 15, 2010
Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III TrialsAtsuo Takashima, Yasuhide Yamada, Takako E Nakajima, et al.
Oncology|May 21, 2026
Retrospective comparison of capecitabine plus oxaliplatin and docetaxel plus S-1 as adjuvant chemotherapy for pathological stage III gastric cancerToru Imai, Hidekazu Hirano, Hirokazu Shoji, et al.
Plos One|June 2, 2022
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancerKotoe Oshima, Hidekazu Hirano, Hirokazu Shoji, et al.
Annals of Surgical Oncology|February 6, 2019
Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective StudyDai Shida, Taro Tanabe, Narikazu Boku, et al.
Pageof 19